目的研究MSCT血管重建和双重化疗栓塞治疗转移性肝癌的效果。
AIM: To study the effect of MSCT vascular reconstruction and chemoembolization through portal vein and liver artery in patients with liver cancer metastases.
结论用MSCT血管重建和肝动脉、门静脉双重化疗栓塞治疗转移性肝癌有一定临床效果，且无明显毒副作用。
CONCLUSION: Vascular restructure with MSCT and chemoembolization through portal vein and liver artery, with no obvious side-effects, are effective for patients with liver cancer metastases.
这种双重药物疗法抑制恶心与呕吐的最佳疗效时间为化疗后的24小时。
This two-drug regimen is most effective in preventing nausea and vomiting in the first 24 hours after chemotherapy.
应用推荐